Qrono Inc

Enabling better medications and faster time-to-market by transforming the design process for long acting, controlled-release formulations.

Qrono is enabling better medications, stronger patient adherence, improved patient outcomes, and faster time-to-market for new medications by transforming the design process for long acting, controlled release drug formulations. These formulations deliver their active agent in a precise manner over time. The long design cycles and high risk of the current trial-and-error design process create a barrier to their widespread adoption. Qrono offers the ability to develop long-acting, controlled release formulations significantly faster than current practice by using a predictive design approach based on proprietary software algorithms and data models. We can achieve the optimal result in up to 85% less time and cost than current best practice. We then license the resulting formulations to